NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
1.220
0.00 (0.00%)
Oct 10, 2024, 4:00 PM EDT - Market closed
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $23.75 million as of October 10, 2024. Its market cap has increased by 128.41% in one year.
Market Cap
23.75M
Enterprise Value
22.65M
1-Year Change
128.41%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $23.75M, a decrease of -63.23%. That is a compound annual growth rate of -29.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2024 | 22.10M | 125.51% |
| Dec 29, 2023 | 9.80M | -29.50% |
| Dec 30, 2022 | 13.90M | -47.55% |
| Dec 31, 2021 | 26.50M | -58.98% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unity Biotechnology | 25.10M |
| Lisata Therapeutics | 24.88M |
| Marker Therapeutics | 24.81M |
| KALA BIO | 24.65M |
| The Oncology Institute | 24.49M |
| Neuronetics | 24.24M |
| Femasys | 24.23M |
| CytoMed Therapeutics | 24.18M |